Eosinophilic skin diseases: A comprehensive review

Clinical Reviews in Allergy and Immunology

Volumn 50, Issue 2, 2016, Pages 189-213

  Long, Hai ^a   Zhang, Guiying ^a   Wang, Ling ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Eosinophilic cellulitis (Wells syndrome); Eosinophilic dermatoses; Eosinophilic fasciitis (Shulman disease); Eosinophilic pustular folliculitis; Granuloma faciale; Recurrent cutaneous eosinophilic vasculitis (RCEV)

Indexed keywords

ADALIMUMAB; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; CLOFAZIMINE; CORTICOSTEROID; DAPSONE; INDOMETACIN; PREDNISONE; PSORALEN; TACROLIMUS; AUTACOID; CYTOKINE;

CELL MIGRATION; CHEMOTAXIS; COMORBIDITY; CRYOTHERAPY; CUTANEOUS EOSINOPHILIC VASCULITIS; CYTOKINE RESPONSE; CYTOTOXICITY; DEGRANULATION; DERMATITIS; DERMATITIS HERPETIFORMIS; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIC FASCIITIS; EOSINOPHILIC PUSTULAR FOLLICULITIS; EOSINOPHILIC SKIN DISEASE; EPILUMINESCENCE MICROSCOPY; EPITHELIOID HEMANGIOMA; EXCISION; FOLLICULITIS; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSION ASSOCIATED EOSINOPHILIC PUSTULAR FOLLICULITIS; INCONTINENTIA PIGMENTI; INFANTILE EOSINOPHILIC PUSTULAR FOLLICULITIS; LOCAL THERAPY; LOW LEVEL LASER THERAPY; NONHUMAN; OFUJI DISEASE; PATHOGENICITY; PROGNOSIS; PSEUDOLYMPHOMA; RECURRENT DISEASE; REVIEW; SKIN ALLERGY; SKIN BIOPSY; SKIN DISEASE; SKIN GRANULOMA; SKIN MANIFESTATION; SYSTEMIC THERAPY; ULTRAVIOLET A RADIATION; URTICARIA PIGMENTOSA; VASCULITIS; WELLS SYNDROME; ANIMAL; DISEASE MANAGEMENT; DISEASE PREDISPOSITION; EOSINOPHIL; EOSINOPHILIA; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN DISEASES;

ANIMALS; CHEMOTAXIS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; DISEASE SUSCEPTIBILITY; EOSINOPHILIA; EOSINOPHILS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PROGNOSIS; SKIN DISEASES;

EID: 84927925995     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-015-8485-8     Document Type: Review

References (227)

1. Montgomery ND, Dunphy CH, Mooberry M et al (2013) Diagnostic complexities of eosinophilia. Arch Pathol Lab Med 137:259-269
2. Furuta GT, Atkins FD, Lee NA, Lee JJ (2014) Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol 113:3-8
3. Helbig G (2014) Advances in the diagnosis and treatment of eosinophilia. Curr Opin Hematol 21:3-7
4. Akuthota P, Weller PF (2012) Eosinophils and disease pathogenesis. Semin Hematol 49:113-119
5. Heymann WR (2006) Eosinophilic dermatoses. J Am Acad Dermatol 55:114-115
6. Bystrom J, Amin K, Bishop-Bailey D (2011) Analysing the eosinophil cationic protein-a clue to the function of the eosinophil granulocyte. Respir Res 12:10
7. Bochner BS, Gleich GJ (2010) What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol 126:16-25, quiz 26-17
8. Cao C, Gu Y, Zhu C et al (2014) Potential roles of eosinophils in cancer therapy: epidemiological studies, experimental models, and clinical pathology. Recent Pat Anticancer Drug Discov 9: 241-248
9. Acharya KR, Ackerman SJ (2014) Eosinophil granule proteins: form and function. J Biol Chem 289:17406-17415
10. Lacy P, Rosenberg HF, Walsh GM (2014) Eosinophil overview: structure, biological properties, and key functions. Methods Mol Biol 1178:1-12
11. Akuthota P, Wang H, Weller PF (2010) Eosinophils as antigenpresenting cells in allergic upper airway disease. Curr Opin Allergy Clin Immunol 10:14-19
12. Jia GQ, Gonzalo JA, Hidalgo A, Wagner D, Cybulsky M, Gutierrez-Ramos JC (1999) Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int Immunol 11:1-10
13. Kato Y, Pawankar R, Kimura Y, Kawana S (2006) Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema. Int Arch Allergy Immunol 139:245-257
14. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ (1991) Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 174:745-748
15. Gleich GJ, Klion AD, Lee JJ, Weller PF (2013) The consequences of not having eosinophils. Allergy 68:829-835
16. Wells GC (1971) Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc 57:46-56
17. Wells GC, Smith NP (1979) Eosinophilic cellulitis. Br J Dermatol 100:101-109
18. Sinno H, Lacroix JP, Lee J et al (2012) Diagnosis and management of eosinophilic cellulitis (Wells’ syndrome): A case series and literature review. Can J Plast Surg 20:91-97
19. Schorr WF, Tauscheck AL, Dickson KB, Melski JW (1984) Eosinophilic cellulitis (Wells’ syndrome): histologic and clinical features in arthropod bite reactions. J Am Acad Dermatol 11: 1043-1049
20. Lin HL, Lin JN, Chen CW, Kuo LC, Lee WC(2009) Eosinophilic cellulitis after honeybee sting. J Formos Med Assoc 108:964-966
21. Friedman IS, Phelps RG, Baral J, Sapadin AN (1998) Wells’ syndrome triggered by centipede bite. Int J Dermatol 37:602-605
22. Koga C, Sugita K, Kabashima K, Matsuoka H, Nakamura M, Tokura Y (2010) High responses of peripheral lymphocytes to mosquito salivary gland extracts in patients withWells syndrome. J Am Acad Dermatol 63:160-161
23. Barreiros H, Matos D, Furtado C, Cunha H, Bartolo E (2012) Wells syndrome in a child triggered by parvovirus B19 infection? J Am Acad Dermatol 67:e166-167
24. Cherng E, McClung AA, Rosenthal HM, Hicks J, Levy ML (2012) Wells’ syndrome associated with parvovirus in a 5-year old boy. Pediatr Dermatol 29:762-764
25. Toulon A, Bourdon-Lanoy E, Hamel D et al (2007) Wells’ syndrome after primoinfection by parvovirus B19 in a child. J Am Acad Dermatol 56:S50-51
26. Ludwig RJ, Grundmann-Kollmann M, Holtmeier W et al (2003) Herpes simplex virus type 2-associated eosinophilic cellulitis (Wells’ syndrome). J Am Acad Dermatol 48:S60-61
27. Reichel M, Isseroff RR, Vogt PJ, Gandour-Edwards R (1991) Wells’ syndrome in children: varicella infection as a precipitating event. Br J Dermatol 124:187-190
28. Tsuda S, Tanaka K, Miyasato M, Nakama T, Sasai Y (1994) Eosinophilic cellulitis (Wells’ syndrome) associated with ascariasis. Acta Derm Venereol 74:292-294
29. Bassukas ID, Gaitanis G, Zioga A, Boboyianni C, Stergiopoulou C (2008) Febrile Bmigrating^ eosinophilic cellulitis with hepatosplenomegaly: adult toxocariasis—a case report. Cases J 1:356
30. Hurni MA, Gerbig AW, Braathen LR, Hunziker T (1997) Toxocariasis and Wells’ syndrome: a causal relationship? Dermatology 195:325-328
31. Heelan K, Ryan JF, Shear NH, Egan CA (2013) Wells syndrome (eosinophilic cellulitis): proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep 7: 113-120
32. Brehmer-Andersson E, Kaaman T, Skog E, Frithz A (1986) The histopathogenesis of the flame figure inWells’ syndrome based on five cases. Acta Derm Venereol 66:213-219
33. Ferrier MC, Janin-Mercier A, Souteyrand P, Bourges M, Hermier C (1988) Eosinophilic cellulitis (Wells’ syndrome): ultrastructural study of a case with circulating immune complexes. Dermatologica 176:299-304
34. Moossavi M, Mehregan DR (2003) Wells’ syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol 42:62-67
35. Seckin D, Demirhan B (2001) Drugs and Wells’ syndrome: a possible causal relationship? Int J Dermatol 40:138-140
36. Spigel GT, Winkelmann RK (1979) Wells’ syndrome. Recurrent granulomatous dermatitis with eosinophilia. Arch Dermatol 115: 611-613
37. Rossini MS, de Souza EM, Cintra ML, Pagnano KB, Chiari AC, Lorand-Metze I (2004) Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol 18:538-542
38. Calvert J, Shors AR, Hornung RL, Poorsattar SP, Sidbury R (2006) Relapse of Wells’ syndrome in a child after tetanusdiphtheria immunization. J Am Acad Dermatol 54:S232-233
39. Koh KJ, Warren L, Moore L, James C, Thompson GN (2003) Wells’ syndrome following thiomersal-containing vaccinations. Australas J Dermatol 44:199-202
40. Moreno M, Luelmo J, Monteagudo M, Bella R, Casanovas A (1997) Wells’ syndrome related to tetanus vaccine. Int J Dermatol 36:524-525
41. Boura P, Sarantopoulos A, Lefaki I, Skendros P, Papadopoulos P (2006) Eosinophilic cellulitis (Wells’ syndrome) as a cutaneous reaction to the administration of adalimumab. Ann Rheum Dis 65:839-840
42. Tugnet N, Youssef A, Whallett AJ (2012) Wells’ syndrome (eosinophilic cellulitis) secondary to infliximab. Rheumatology (Oxford) 51:195-196
43. Winfield H, Lain E, Horn T, Hoskyn J (2006) Eosinophilic cellulitislike reaction to subcutaneous etanercept injection. Arch Dermatol 142:218-220
44. Nakazato S, Fujita Y, Hamade Y et al (2013) Wells’ syndrome associated with chronic myeloid leukaemia. Acta Derm Venereol 93:375-376
45. Gambichler T, Othlinghaus N, Rotterdam S, Altmeyer P, Stucker M(2009) ImpetiginizedWells’ syndrome in a patient with chronic lymphocytic leukaemia. Clin Exp Dermatol 34:e274-275
46. Spinelli M, Frigerio E, Cozzi A, Garutti C, Garavaglia MC, Altomare G (2008) Bullous Wells’ syndrome associated with non-Hodgkin’s lymphocytic lymphoma. Acta Derm Venereol 88:530-531
47. Rajpara A, Liolios A, Fraga G, Blackmon J (2014) Recurrent paraneoplastic wells syndrome in a patient with metastatic renal cell cancer. Dermatol Online J 20(6)
48. Hirsch K, Ludwig RJ, Wolter M et al (2005) Eosinophilic cellulitis (Wells’ syndrome) associated with colon carcinoma. J Dtsch Dermatol Ges 3:530-531
49. Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K (2004) Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 31:514-519
50. Huang CF, Chen YF, Wang WM, Chiang CP (2013) Wells’ syndrome associated with Churg-Strauss syndrome: correlation with mast cell distribution. Int J Dermatol 52:214-216
51. Lee SC, Shin SS, Lee JB, Won YH (2000) Wells syndrome associated with Churg-Strauss syndrome. J Am Acad Dermatol 43: 556-557
52. Lee SH, Roh MR, Jee H, Chung KY, Jung JY (2011) Wells’ syndrome associated with Churg-Strauss syndrome. Ann Dermatol 23:497-500
53. Schuttelaar ML, Jonkman MF (2003) Bullous eosinophilic cellulitis (Wells’ syndrome) associated with Churg-Strauss syndrome. J Eur Acad Dermatol Venereol 17:91-93
54. Sakaria SS, Ravi A, Swerlick R, Sitaraman S (2007) Wells’ syndrome associated with ulcerative colitis: a case report and literature review. J Gastroenterol 42:250-252
55. Bogenrieder T, Griese DP, Schiffner R et al (1997) Wells’ syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol 137:978-982
56. Tsuji Y, Kawashima T, Yokota K et al (2002)Wells’ syndrome as a manifestation of hypereosinophilic syndrome. Br J Dermatol 147: 811-812
57. Arca E, Kose O, Karslioglu Y, Tastan HB, Demiriz M (2007) Bullous eosinophilic cellulitis succession with eosinophilic pustular folliculitis without eosinophilia. J Dermatol 34:80-85
58. Yagi H, Tokura Y, Matsushita K, Hanaoka K, Furukawa F, Takigawa M (1997) Wells’ syndrome: a pathogenic role for circulating CD4+CD7−T cells expressing interleukin-5 mRNA. Br J Dermatol 136:918-923
59. Espana A, Sanz ML, Sola J, Gil P (1999) Wells’ syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 140:127-130
60. Simon HU, Plotz S, Simon D et al (2003) Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells’ syndrome. Eur J Immunol 33:834-839
61. Powell JG, Ramsdell A, Rothman IL (2012) Eosinophilic cellulitis (Wells syndrome) in a pediatric patient: a case report and review of the literature. Cutis 89:191-194
62. Chung CL, Cusack CA (2006)Wells syndrome: an enigmatic and therapeutically challenging disease. J Drugs Dermatol 5:908-911
63. Keller EC, Tomecki KJ, Alraies MC (2012) Distinguishing cellulitis from its mimics. Cleve Clin J Med 79:547-552
64. Ferreli C, Pinna AL, Atzori L, Aste N (1999) Eosinophilic cellulitis (Well’s syndrome): a new case description. J Eur Acad Dermatol Venereol 13:41-45
65. Falagas ME, Vergidis PI (2005) Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 142:47-55
66. Verma P, Singal A, Sharma S (2012) Idiopathic bullous eosinophilic cellulitis (Wells syndrome) responsive to topical tacrolimus and antihistamine combination. Indian J Dermatol Venereol Leprol 78:378-380
67. Rongioletti F, Fausti V, Kempf W, Rebora A, Parodi A (2011) Eosinophilic annular erythema: an expression of the clinical and pathological polymorphism of Wells syndrome. J Am Acad Dermatol 65:e135-137
68. Howes R, Girgis L, Kossard S (2008) Eosinophilic annular erythema: a subset ofWells’ syndrome or a distinct entity? Australas J Dermatol 49:159-163
69. El-Khalawany M, Al-Mutairi N, Sultan M, Shaaban D (2013) Eosinophilic annular erythema is a peculiar subtype in the spectrum ofWells syndrome: a multicentre long-term follow-up study. J Eur Acad Dermatol Venereol 27:973-979
70. Ratzinger G, Zankl J, Zelger B (2013) Wells syndrome and its relationship to Churg-Strauss syndrome. Int J Dermatol 52:949-954
71. Govoni M, Colina M, Cavazzini L, Trotta F (2007) Churg-Strauss syndrome andWells syndrome: coincidence or pathogenetic association? A new case report. Clin Exp Rheumatol 25:S41
72. Mitchell AJ, Anderson TF, Headington JT, Rasmussen JE (1984) Recurrent granulomatous dermatitis with eosinophilia.Wells’ syndrome. Int J Dermatol 23:198-202
73. Leiferman KM, Peters MS (2006) Reflections on eosinophils and flame figures: where there’s smoke there’s not necessarily Wells syndrome. Arch Dermatol 142:1215-1218
74. Qiao J, Sun CE, Zhu W, Zhu D, Fang H (2013) Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease? Int J Clin Exp Pathol 6:1683-1687
75. Wood C, Miller AC, Jacobs A, Hart R, Nickoloff BJ (1986) Eosinophilic infiltration with flame figures. A distinctive tissue reaction seen in Wells’ syndrome and other diseases. Am J Dermatopathol 8:186-193
76. Bansal M, Rai T, Pandey SS (2012) Wells syndrome. Indian Dermatol Online J 3:187-189
77. Coldiron BM, Robinson JK (1989) Low-dose alternate-day prednisone for persistent Wells’ syndrome. Arch Dermatol 125:1625-1626
78. Moon SH, Shin MK (2013) Bullous eosinophilic cellulitis in a child treated with dapsone. Pediatr Dermatol 30:e46-47
79. Ohtsuka T (2009) Oral tacrolimus treatment for refractory eosinophilic cellulitis. Clin Exp Dermatol 34:e597-598
80. Kim SH, Kwon JE, Kim HB (2013) Successful treatment of steroid-dependent eosinophilic cellulitis with cyclosporine. Allergy Asthma Immunol Res 5:62-64
81. Sarin KY, Fiorentino D (2012) Treatment of recalcitrant eosinophilic cellulitis with adalimumab. Arch Dermatol 148:990-992
82. Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47:29-35
83. Iwasaki M, Saito K, Takemura M et al (2003) TNF-alpha contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 112:134-140
84. Gandhi RK, Coloe J, Peters S, Zirwas M, Darabi K (2011) Wells syndrome (eosinophilic cellulitis): a clinical imitator of bacterial cellulitis. J Clin Aesthet Dermatol 4:55-57
85. Herr H, Koh JK (2001) Eosinophilic cellulitis (Wells’ syndrome) successfully treated with low-dose cyclosporine. J Korean Med Sci 16:664-668
86. Aberer W, Konrad K, Wolff K (1988) Wells’ syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 18:105-114
87. Teixeira DA, Estrozi B, Ianhez M(2013)Granuloma faciale: a rare disease from a dermoscopy perspective. An Bras Dermatol 88:97-100
88. Thiyanaratnam J, Doherty SD, Krishnan B, Hsu S (2009) Granuloma faciale: case report and review. Dermatol Online J 15:3
89. Pinkus H (1952) Facial granuloma. Dermatologica 105:85-99
90. Lever WF, Leeper RW (1950) Eosinophilic granuloma of the skin; report of cases representing the two different diseases described as eosinophilic granuloma. Arch Derm Syphilol 62:85-96
91. Cobane JH, Straith CL, Pinkus H (1950) Facial granulomas with eosinophilia; their relation to other eosinophilic granulomas of the skin and to reticulogranuloma. Arch Derm Syphilol 61:442-454
92. Ortonne N, Wechsler J, Bagot M, Grosshans E, Cribier B (2005) Granuloma faciale: a clinicopathologic study of 66 patients. J Am Acad Dermatol 53:1002-1009
93. Marcoval J, Moreno A, Peyr J (2004) Granuloma faciale: a clinicopathological study of 11 cases. J Am Acad Dermatol 51:269-273
94. Gauger A, Ronet C, Schnopp C et al (2005) High local interleukin 5 production in granuloma faciale (eosinophilicum): role of clonally expanded skin-specific CD4+ cells. Br J Dermatol 153:454-457
95. Selvaag E, Roald B (2000) Immunohistochemical findings in granuloma faciale. The role of eosinophilic granulocytes. J Eur Acad Dermatol Venereol 14:517-518
96. Nakahara T, Moroi Y, Tashiro A, Kiryu H, Furue M (2010) The interaction of inflammatory cells in granuloma faciale. Dermatology Reports 2:e17
97. Smoller BR, Bortz J (1993) Immunophenotypic analysis suggests that granuloma faciale is a gamma-interferon-mediated process. J Cutan Pathol 20:442-446
98. Barnadas MA, Curell R, Alomar A (2006) Direct immunofluorescence in granuloma faciale: a case report and review of literature. J Cutan Pathol 33:508-511
99. Nasiri S, Rahimi H, Farnaghi A, Asadi-Kani Z (2010) Granuloma faciale with disseminated extra facial lesions. Dermatol Online J 16:5
100. Ludwig E, Allam JP, Bieber T, Novak N (2003) New treatment modalities for granuloma faciale. Br J Dermatol 149:634-637
101. Leite I, Moreira A, Guedes R, Furtado A, Ferreira EO, Baptista A (2011) Granuloma faciale of the scalp. Dermatol Online J 17:6
102. Gupta L, Naik H, Kumar NM, Kar HK (2012) Granuloma faciale with extrafacial involvement and response to tacrolimus. J Cutan Aesthet Surg 5:150-152
103. Surana TV, Arghyaprasun G, Saugato B, Falguni N, Gobinda C, Chinmay H (2013) Granuloma faciale: exclusively extrafacial. Indian J Dermatol 58:245
104. Nogueira A, Lisboa C, Duarte AF et al (2011) Granuloma faciale with subglottic eosinophilic angiocentric fibrosis: case report and review of the literature. Cutis 88:77-82
105. Roberts PF, McCann BG (1985) Eosinophilic angiocentric fibrosis of the upper respiratory tract: a mucosal variant of granuloma faciale? A report of three cases. Histopathology 9:1217-1225
106. Jain R, Robblee JV, O’Sullivan-Mejia E et al (2008) Sinonasal eosinophilic angiocentric fibrosis: a report of four cases and review of literature. Head Neck Pathol 2:309-315
107. Watanabe N, Moriwaki K (2006) Atypical eosinophilic angiocentric fibrosis on nasal septum. Auris Nasus Larynx 33: 355-358
108. LeBoit PE (2002) Granuloma faciale: a diagnosis deserving of dignity. Am J Dermatopathol 24:440-443
109. Caldarola G, Zalaudek I, Argenziano G, Bisceglia M, Pellicano R (2011) Granuloma faciale: a case report on long-term treatment with topical tacrolimus and dermoscopic aspects. Dermatol Ther 24:508-511
110. Ziemer M, Schwede K, Simon JC, Paasch U (2013) Atypical erythema elevatum diutinum or extrafacial granuloma faciale? J Dtsch Dermatol Ges 11:178-180
111. Lallas A, Sidiropoulos T, Lefaki I, Tzellos T, Sotiriou E, Apalla Z (2012) Photoletter to the editor: dermoscopy of granuloma faciale. J Dermatol Case Rep 6:59-60
112. Panagiotopoulos A, Anyfantakis V, Rallis E et al (2006) Assessment of the efficacy of cryosurgery in the treatment of granuloma faciale. Br J Dermatol 154:357-360
113. Cheung ST, Lanigan SW (2005) Granuloma faciale treated with the pulsed-dye laser: a case series. Clin Exp Dermatol 30:373-375
114. Fikrle T, Pizinger K (2010) Granuloma faciale treated with 595-nm pulsed dye laser. Dermatol Surg 37:102-104
115. Erceg A, de Jong EM, van de Kerkhof PC, Seyger MM (2013) The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. J Am Acad Dermatol 69:609-615, e608
116. Tojo G, Fujimura T, Kambayashi Y, Kikuchi K, Aiba S (2012) Successful treatment of granuloma faciale with topical tacrolimus: a case report and immunohistochemical study. Case Rep Dermatol 4:158-162
117. Ofuji S (1987) Eosinophilic pustular folliculitis. Dermatologica 174:53-56
118. Fujiyama T, Tokura Y (2013) Clinical and histopathological differential diagnosis of eosinophilic pustular folliculitis. J Dermatol 40:419-423
119. Ofuji S, Ogino A, Horio T, Oseko T, Uehara M (1970) Eosinophilic pustular folliculitis. Acta Derm Venereol 50:195-203
120. Lankerani L, Thompson R (2010) Eosinophilic pustular folliculitis: case report and review of the literature. Cutis 86:190-194
121. Nervi SJ, Schwartz RA, Dmochowski M (2006) Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol 55: 285-289
122. Katoh M, Nomura T, Miyachi Y, Kabashima K (2013) Eosinophilic pustular folliculitis: a review of the Japanese published works. J Dermatol 40:15-20
123. Afonso JP, Tomimori J, Michalany NS, Nonogaki S, Porro AM (2012) Pruritic papular eruption and eosinophilic folliculitis associated with human immunodeficiency virus (HIV) infection: a histopathological and immunohistochemical comparative study. J Am Acad Dermatol 67:269-275
124. Buezo GF, Fraga J, Abajo P, Rios L, Dauden E, Garcia-Diez A (1998) HIV-Associated eosinophilic folliculitis and follicular mucinosis. Dermatology 197:178-180
125. Rajendran PM, Dolev JC, Heaphy MR Jr, Maurer T (2005) Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol 141:1227-1231
126. Keida T, Hayashi N, Kawashima M (2004) Eosinophilic pustular folliculitis following autologous peripheral blood stem-cell transplantation. J Dermatol 31:21-26
127. Patrizi A, Di Lernia V, Neri I, Gherlinzoni F (1992) Eosinophilic pustular folliculitis (Ofuji’s disease) and non-Hodgkin lymphoma. Acta Derm Venereol 72:146-147
128. Zitelli K, Fernandes N, Adams BB (2014) Eosinophilic folliculitis occurring after stem cell transplant for acute lymphoblastic leukemia: a case report and review. Int J Dermatol. doi:10.1111/ijd.12521
129. Opie KM, Heenan PJ, Delaney TA, Rohr JB (2003) Two cases of eosinophilic pustular folliculitis associated with parasitic infestations. Australas J Dermatol 44:217-219
130. Hernandez-Martin A, Nuno-Gonzalez A, Colmenero I, Torrelo A (2013) Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol 68:150-155
131. Hsu PJ, Huang CJ, Wu MT (2005) Pathergy in atypical eosinophilic pustular folliculitis. Int J Dermatol 44:203-205
132. Ellis E, Scheinfeld N (2004) Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol 5:189-197
133. Laing ME, Laing TA, Mulligan NJ, Keane FM (2006) Eosinophilic pustular folliculitis induced by chemotherapy. J Am Acad Dermatol 54:729-730
134. Ooi CG, Walker P, Sidhu SK, Gordon LA, Marshman G (2006) Allopurinol induced generalized eosinophilic pustular folliculitis. Australas J Dermatol 47:270-273
135. Mizoguchi S, Setoyama M, Higashi Y, Hozumi H, Kanzaki T (1998) Eosinophilic pustular folliculitis induced by carbamazepine. J Am Acad Dermatol 38:641-643
136. Mabuchi T, Matsuyama T, Ozawa A (2011) Case of eosinophilic pustular folliculitis associated with pregnancy. J Dermatol 38: 1191-1193
137. Kus S, Candan I, Ince U, Uygur T (2006) Eosinophilic pustular folliculitis (Ofuji’s disease) exacerbated with pregnancies. J Eur Acad Dermatol Venereol 20:1347-1348
138. Gul U, Kilic A, Demiriz M (2007) Eosinophilic pustular folliculitis: the first case associated with hepatitis C virus. J Dermatol 34: 397-399
139. Teraki Y, Konohana I, Shiohara T, Nagashima M, Nishikawa T (1993) Eosinophilic pustular folliculitis (Ofuji’s disease). Immunohistochemical analysis. Arch Dermatol 129:1015-1019
140. Satoh T, Shimura C, Miyagishi C, Yokozeki H (2010) Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji’s disease): a proposed mechanism of action. Acta Derm Venereol 90:18-22
141. Nakahigashi K, Doi H, Otsuka A et al (2012) PGD2 induces eotaxin-3 via PPARgamma from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol 129:536-543
142. Kataoka N, Satoh T, Hirai A, Saeki K, Yokozeki H (2013) Indomethacin inhibits eosinophil migration to prostaglandin D2: therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis. Immunology 140:78-86
143. Satoh T, Ito Y, Miyagishi C, Yokozeki H (2011) Basophils infiltrate skin lesions of eosinophilic pustular folliculitis (Ofuji’s disease). Acta Derm Venereol 91:371-372
144. Murayama T, Nakamura K, Tsuchida T (2014) Eosinophilic pustular folliculitis with extensive distribution: correlation of serum TARC levels and peripheral blood eosinophil numbers. Int J Dermatol. doi:10.1111/ijd.12281
145. Yokobayashi H, Sugaya M, Miyagaki T et al (2013) Analysis of serum chemokine levels in patients with HIV-associated eosinophilic folliculitis. J Eur Acad Dermatol Venereol 27:e212-216
146. Satoh T, Ikeda H, Yokozeki H (2013) Acrosyringeal involvement of palmoplantar lesions of eosinophilic pustular folliculitis. Acta Derm Venereol 93:99
147. Romano C, Rubegni P, De Aloe G et al (2003) Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. J Eur Acad Dermatol Venereol 17:10-13
148. Rattana-Apiromyakij N, Kullavanijaya P (2000) Eosinophilic pustular folliculitis: report of seven cases in Thailand. J Dermatol 27: 195-203
149. Izumi K, Yanagi T, Akiyama M, Moriuchi R, Arita K, Shimizu H (2013) Intractable erythematous plaques on the hands: palmoplantar eosinophilic pustular folliculitis. Int J Dermatol 52: 1274-1275
150. Tsuboi H, Niiyama S, Katsuoka K (2004) Eosinophilic pustular folliculitis (Ofuji disease) manifested as pustules on the palms and soles. Cutis 74:107-110
151. Lucky AW, Esterly NB, Heskel N, Krafchik BR, Solomon LM (1984) Eosinophilic pustular folliculitis in infancy. Pediatr Dermatol 1:202-206
152. Toyonaga E, Abe R, Moriuchi R, Ito K, Abe Y, Shimizu H (2013) Indomethacin for refractory infantile eosinophilic pustular folliculitis. JAMA Dermatol 149:367-368
153. Lee WJ, Won KH, Won CH et al (2014) Facial and extrafacial eosinophilic pustular folliculitis: a clinical and histopathological comparative study. Br J Dermatol 170:1173-1176
154. Parker SR, Parker DC, McCall CO (2006) Eosinophilic folliculitis in HIV-infected women: case series and review. Am J Clin Dermatol 7:193-200
155. Giard F, Marcoux D, McCuaig C, Powell J, Russo P (1991) Eosinophilic pustular folliculitis (Ofuji disease) in childhood: a review of four cases. Pediatr Dermatol 8:189-193
156. Asgari M, Leiferman KM, Piepkorn M, Kuechle MK (2006) Neonatal eosinophilic pustulosis. Int J Dermatol 45:131-134
157. Finelt N, Kristal L (2013) Patient characteristics of neonatal eosinophilic pustulosis. Pediatr Dermatol 30:e204-207
158. Holmes RB, Martins C, Horn T (2002) The histopathology of folliculitis in HIV-infected patients. J Cutan Pathol 29:93-95
159. Buckley DA, Munn SE, Higgins EM (2001) Neonatal eosinophilic pustular folliculitis. Clin Exp Dermatol 26:251-255
160. Duarte AM, Kramer J, Yusk JW, Paller A, Schachner LA (1993) Eosinophilic pustular folliculitis in infancy and childhood. Am J Dis Child 147:197-200
161. Ota M, Shimizu T, Hashino S, Shimizu H (2004) Eosinophilic folliculitis in a patient after allogeneic bone marrow transplantation: case report and review of the literature. Am J Hematol 76: 295-296
162. Fukamachi S, Kabashima K, Sugita K, Kobayashi M, Tokura Y (2009) Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis. Acta Derm Venereol 89:155-159
163. Yoshifuku A, Higashi Y, Matsushita S, Kawai K, Kanekura T (2013) Transdermal nicotine patches for eosinophilic pustular folliculitis. J Dermatol 40:711-714
164. Schmieder A, Damm F, Haus G, Lentz K, Goerdt S, Peitsch WK (2013) Extended eosinophilic pustular folliculitis with reactive bonemarrow hypereosinophilia responsive to combined treatment with indomethacin, dapsone, and narrow-band UVB phototherapy. J Am Acad Dermatol 69:e312-314
165. Alonso-Castro L, Perez-Garcia B, Gonzalez-Garcia C, Jaen-Olasolo P (2012) Eosinophilic pustular folliculitis in infancy: report of a new case. Dermatol Online J 18:6
166. Carlson JA, Chen KR (2007) Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol 29:32-43
167. Chen KR, Su WP, Pittelkow MR, Conn DL, George T, Leiferman KM (1996) Eosinophilic vasculitis in connective tissue disease. J Am Acad Dermatol 35:173-182
168. Yomoda M, Inoue M, Nakama T, Mori O, Chen KR, Hashimoto T (1999) Cutaneous eosinophilic vasculitis associated with rheumatoid arthritis. Br J Dermatol 140:754-755
169. Liao YH, Su YW, Tsay W, Chiu HC (2005) Association of cutaneous necrotizing eosinophilic vasculitis and deep vein thrombosis in hypereosinophilic syndrome. Arch Dermatol 141:1051-1053
170. Chen KR, Pittelkow MR, Su D, Gleich J, Newman W, Leiferman KM (1994) Recurrent cutaneous necrotizing eosinophilic vasculitis. A novel eosinophil-mediated syndrome. Arch Dermatol 130: 1159-1166
171. Chen KR, Su WP, Pittelkow MR, Leiferman KM (1995) Eosinophilic vasculitis syndrome: recurrent cutaneous eosinophilic necrotizing vasculitis. Semin Dermatol 14:106-110
172. Li W, Cao W, Song H, Ciu Y, Lu X, Zhang F (2013) Recurrent cutaneous necrotizing eosinophilic vasculitis: a case report and review of the literature. Diagn Pathol 8:185
173. Resnick MB, Weller PF (1993) Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 8:349-355
174. Sugiyama M, Nozaki Y, Ikoma S, Kinoshita K, Funauchi M (2013) Successful treatment with tacrolimus in a case of the glucocorticoid-dependent recurrent cutaneous eosinophilic vasculitis. Ann Dermatol 25:252-254
175. Launay D, Delaporte E, Gillot JM, Janin A, Hachulla E (2000) An unusual cause of vascular purpura: recurrent cutaneous eosinophilic necrotizing vasculitis. Acta Derm Venereol 80:394-395
176. Kiorpelidou D, Gaitanis G, Zioga A, Tsili AC, Bassukas ID (2011) Chronic periaortitis (retroperitoneal fibrosis) concurrent with recurrent cutaneous eosinophilic vasculitis. Case Rep Dermatol Med 2011:548634
177. Peng Y, Wang P, Chen X (2012) A case of recurrent cutaneous necrotizing eosinophilic vasculitis. The Chinese Journal of Dermatovenereology 26:528-529
178. Song L, Zeng S, Sun J (2005) A case of recurrent cutaneous necrotizing eosinophilic vasculitis. Chinese Journal of Dermatology 38:709
179. Zhou N, Che Y, Liu Q (2007) Recurrent cutaneous necrotizing eosinophilic vasculitis. China Journal of Leprosy and Skin Diseases 23:429-430
180. Sakuma-Oyama Y, Nishibu A, Oyama N, Saito M, Nakamura K, Kaneko F (2003) A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate. Br J Dermatol 149:901-903
181. Tsunemi Y, Saeki H, Ihn H, Tamaki K (2005) Recurrent cutaneous eosinophilic vasculitis presenting as annular urticarial plaques. Acta Derm Venereol 85:380-381
182. Tanglertsampan C, Tantikun N, Noppakun N, Pinyopornpanit V (2007) Indomethacin for recurrent cutaneous necrotizing eosinophilic vasculitis. J Med Assoc Thai 90:1180-1182
183. Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. Lancet 367:241-251
184. Pinal-Fernandez I, Selva-O’ Callaghan A, Grau JM (2014) Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 13:379-382
185. Shulman LE (1975) Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 88:70-86
186. Lebeaux D, Sene D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26:449-458
187. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17:221-231
188. Bujold J, Boivin C, Amin M, Bouchard JP, Soucy J (2014) Eosinophilic fasciitis occurring under treatment with natalizumab for multiple sclerosis. J Cutan Med Surg 18:69-71
189. Sugiura K, Matsumoto T, Muro Y, Akiyama M (2013) Unilaterally dominant eosinophilic fasciitis after influenza vaccination. J Am Acad Dermatol 69:e269-270
190. de Boysson H, Cheze S, Chapon F, Le Mauff B, Auzary C, Geffray L (2013) Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuria. Joint Bone Spine 80:208-210
191. Ferguson JS, Bosworth J, Min T, Mercieca J, Holden CA (2013) Eosinophilic fasciitis associated with hypereosinophilia, abnormal bone-marrowkaryotype and inversion of chromosome 5. Clin Exp Dermatol 39:150-153
192. Eklund KK, Anttila P, Leirisalo-Repo M (2003) Eosinophilic fasciitis, myositis and arthritis as earlymanifestations of peripheral Tcell lymphoma. Scand J Rheumatol 32:376-377
193. Lebeaux D, Frances C, Barete S et al (2012) Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 51:557-561
194. Granter SR, Barnhill RL, Duray PH (1996) Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol 18:465-473
195. Sillo P, Pinter D, Ostorhazi E et al (2012) Eosinophilic fasciitis associated with Mycoplasma arginini infection. J Clin Microbiol 50:1113-1117
196. Mallepalli JR, Quinet RJ, Sus R (2008) Eosinophilic fasciitis induced by fire ant bites. Ochsner J 8:114-118
197. Schaffer JV, McNiff JM, Seropian S, Cooper DL, Bolognia JL (2005) Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol 53:591-601
198. Moore TL, Zuckner J (1980) Eosinophilic fasciitis. Semin Arthritis Rheum 9:228-235
199. Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG (2006) Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 26:165-171
200. Ciferska H, Horak P, Hermanova Z et al (2007) The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value. Clin Rheumatol 26: 723-728
201. Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K (2003) Circulating soluble CD40 ligand in patients with eosinophilic fasciitis. Ann Rheum Dis 62:190-191
202. Asano Y, Ihn H, Jinnin M, Tamaki Z, Tamaki K, Sato S (2014) Serum levels of matrix metalloproteinase-13 in patients with eosinophilic fasciitis. J Dermatol 41:746-748
203. Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K (2004) Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis. Br J Dermatol 151:407-412
204. Toquet C, Hamidou MA, Renaudin K et al (2003) In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol 30:1811-1815
205. Endo Y, Tamura A, Matsushima Y et al (2007) Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 26:1445-1451
206. Quintero-Del-Rio AI, Punaro M, Pascual V (2002) Faces of eosinophilic fasciitis in childhood. J Clin Rheumatol 8:99-103
207. Chalker RB, Dickey BF, Rosenthal NC, Simms RW (1991) Extrapulmonary thoracic restriction (hidebound chest) complicating eosinophilic fasciitis. Chest 100:1453-1455
208. Moriguchi M, Terai C, Kuroki S et al (1998) Eosinophilic fasciitis complicated with peripheral polyneuropathy. InternMed 37:417-420
209. Killen JW, Swift GL, White RJ (2000) Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad Med J 76:36-37
210. Rizzo S (2002) Eosinophilic pleuropericarditis and fasciitis. A new case. Monaldi Arch Chest Dis 57:311-313
211. Kirschstein M, Helmchen U, Jensen R, Kuster RM, Lehmann H (1999) Kidney involvement in a 17-year-old boy with eosinophilic fasciitis. Clin Nephrol 52:183-187
212. Herson S, Brechignac S, Piette JC et al (1990) Capillary microscopy during eosinophilic fasciitis in 15 patients: distinction from systemic scleroderma. Am J Med 88:598-600
213. Shulman LE (1984) Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol 11:569-570
214. Nakajima H, Fujiwara S, Shinoda K, Ohsawa N (1997) Magnetic resonance imaging and serum aldolase concentration in eosinophilic fasciitis. Intern Med 36:654-656
215. Fujimoto M, Sato S, Ihn H, Kikuchi K, Yamada N, Takehara K (1995) Serumaldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol 22:563-565
216. Desvignes-Engelbert A, Sauliere N, Loeuille D, Blum A, Chary-Valckenaere I (2010) From diagnosis to remission: place of MRI in eosinophilic fasciitis. Clin Rheumatol 29:1461-1464
217. Baumann F, Bruhlmann P, Andreisek G, Michel BA, Marincek B, Weishaupt D (2005) MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR Am J Roentgenol 184:169-174
218. Moulton SJ, Kransdorf MJ, Ginsburg WW, Abril A, Persellin S (2005) Eosinophilic fasciitis: spectrum of MRI findings. AJR Am J Roentgenol 184:975-978
219. Liou CH, Huang GS, Taylor JA, Juan CJ, Gao HW, Chen CY (2003) Eosinophilic fasciitis in a military recruit: MRI evaluation with clinical correlation. Skeletal Radiol 32:52-57
220. Dybowski F, Neuen-Jacob E, Braun J (2008) Eosinophilic fasciitis and myositis: use of imaging modalities for diagnosis and monitoring. Ann Rheum Dis 67:572-574
221. Kissin EY, Garg A, Grayson PC et al (2013) Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis. J Clin Rheumatol 19:382-385
222. Serratrice G, Pellissier JF, Roux H, Quilichini P (1990) Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia. Muscle Nerve 13:385-395
223. Steenland K, Goldsmith DF (1995) Silica exposure and autoimmune diseases. Am J Ind Med 28:603-608
224. de Masson A, Bouaziz JD, Peffault de Latour R et al (2013) Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore) 92:69-81
225. Poliak N, Orange JS, Pawel BR, Weiss PF (2011) Eosinophilic fasciitis mimicking angioedema and treatment response to infliximab in a pediatric patient. Ann Allergy Asthma Immunol 106:444-445
226. Schiener R, Behrens-Williams SC, Gottlober P, Pillekamp H, Peter RU, Kerscher M (2000) Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol 142:804-807
227. Kim SW, Rice L, Champlin R, Udden MM (1997) Aplastic anemia in eosinophilic fasciitis: responses to immunosuppression and marrow transplantation. Haematologia (Budap) 28: 131-137